Global Infectious Disease Diagnostics Testing Market Research Report 2025(Status and Outlook)
Description
Report Overview
In hospitals, infectious disease specialists help ensure the timely diagnosis and treatment of acute infections by recommending the appropriate diagnostic tests to identify the source of the infection and by recommending the appropriate antibiotic to treat the infection.
The global Infectious Disease Diagnostics Testing market size was estimated at USD 17700.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 3.50% during the forecast period.
This report provides a deep insight into the global Infectious Disease Diagnostics Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Infectious Disease Diagnostics Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Infectious Disease Diagnostics Testing market in any manner.
Global Infectious Disease Diagnostics Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott_x000D_
bioMérieux_x000D_
Diasorin_x000D_
Roche Diagnostic_x000D_
Beckman Coulter_x000D_
Becton, Dickinson and Company_x000D_
Bio-Rad Laboratories_x000D_
Cavidi_x000D_
Cepheid_x000D_
Corgenix_x000D_
Diaxonhit_x000D_
Eiken Chemical_x000D_
EMD Millipore_x000D_
Epitope Diagnostic_x000D_
EUROIMMUN_x000D_
Gold Standard Diagnostics_x000D_
Hologic_x000D_
Immunetics_x000D_
InBios International
Market Segmentation (by Type)
Molecular Diagnostic Test_x000D_
POC Infectious Disease Diagnostics Test
Market Segmentation (by Application)
Hospital_x000D_
Academics Research_x000D_
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Infectious Disease Diagnostics Testing Market
Overview of the regional outlook of the Infectious Disease Diagnostics Testing Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Infectious Disease Diagnostics Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Infectious Disease Diagnostics Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
In hospitals, infectious disease specialists help ensure the timely diagnosis and treatment of acute infections by recommending the appropriate diagnostic tests to identify the source of the infection and by recommending the appropriate antibiotic to treat the infection.
The global Infectious Disease Diagnostics Testing market size was estimated at USD 17700.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 3.50% during the forecast period.
This report provides a deep insight into the global Infectious Disease Diagnostics Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Infectious Disease Diagnostics Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Infectious Disease Diagnostics Testing market in any manner.
Global Infectious Disease Diagnostics Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott_x000D_
bioMérieux_x000D_
Diasorin_x000D_
Roche Diagnostic_x000D_
Beckman Coulter_x000D_
Becton, Dickinson and Company_x000D_
Bio-Rad Laboratories_x000D_
Cavidi_x000D_
Cepheid_x000D_
Corgenix_x000D_
Diaxonhit_x000D_
Eiken Chemical_x000D_
EMD Millipore_x000D_
Epitope Diagnostic_x000D_
EUROIMMUN_x000D_
Gold Standard Diagnostics_x000D_
Hologic_x000D_
Immunetics_x000D_
InBios International
Market Segmentation (by Type)
Molecular Diagnostic Test_x000D_
POC Infectious Disease Diagnostics Test
Market Segmentation (by Application)
Hospital_x000D_
Academics Research_x000D_
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Infectious Disease Diagnostics Testing Market
Overview of the regional outlook of the Infectious Disease Diagnostics Testing Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Infectious Disease Diagnostics Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Infectious Disease Diagnostics Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
176 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Infectious Disease Diagnostics Testing
- 1.2 Key Market Segments
- 1.2.1 Infectious Disease Diagnostics Testing Segment by Type
- 1.2.2 Infectious Disease Diagnostics Testing Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Infectious Disease Diagnostics Testing Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Infectious Disease Diagnostics Testing Market Size (M USD) Estimates and Forecasts (2020-2033)
- 2.1.2 Global Infectious Disease Diagnostics Testing Sales Estimates and Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Infectious Disease Diagnostics Testing Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Infectious Disease Diagnostics Testing Product Life Cycle
- 3.3 Global Infectious Disease Diagnostics Testing Sales by Manufacturers (2020-2025)
- 3.4 Global Infectious Disease Diagnostics Testing Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Infectious Disease Diagnostics Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Infectious Disease Diagnostics Testing Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Infectious Disease Diagnostics Testing Market Competitive Situation and Trends
- 3.8.1 Infectious Disease Diagnostics Testing Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Infectious Disease Diagnostics Testing Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Infectious Disease Diagnostics Testing Industry Chain Analysis
- 4.1 Infectious Disease Diagnostics Testing Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Infectious Disease Diagnostics Testing Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Infectious Disease Diagnostics Testing Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Infectious Disease Diagnostics Testing Market
- 5.7 ESG Ratings of Leading Companies
- 6 Infectious Disease Diagnostics Testing Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Infectious Disease Diagnostics Testing Sales Market Share by Type (2020-2025)
- 6.3 Global Infectious Disease Diagnostics Testing Market Size Market Share by Type (2020-2025)
- 6.4 Global Infectious Disease Diagnostics Testing Price by Type (2020-2025)
- 7 Infectious Disease Diagnostics Testing Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Infectious Disease Diagnostics Testing Market Sales by Application (2020-2025)
- 7.3 Global Infectious Disease Diagnostics Testing Market Size (M USD) by Application (2020-2025)
- 7.4 Global Infectious Disease Diagnostics Testing Sales Growth Rate by Application (2020-2025)
- 8 Infectious Disease Diagnostics Testing Market Sales by Region
- 8.1 Global Infectious Disease Diagnostics Testing Sales by Region
- 8.1.1 Global Infectious Disease Diagnostics Testing Sales by Region
- 8.1.2 Global Infectious Disease Diagnostics Testing Sales Market Share by Region
- 8.2 Global Infectious Disease Diagnostics Testing Market Size by Region
- 8.2.1 Global Infectious Disease Diagnostics Testing Market Size by Region
- 8.2.2 Global Infectious Disease Diagnostics Testing Market Size Market Share by Region
- 8.3 North America
- 8.3.1 North America Infectious Disease Diagnostics Testing Sales by Country
- 8.3.2 North America Infectious Disease Diagnostics Testing Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Infectious Disease Diagnostics Testing Sales by Country
- 8.4.2 Europe Infectious Disease Diagnostics Testing Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Infectious Disease Diagnostics Testing Sales by Region
- 8.5.2 Asia Pacific Infectious Disease Diagnostics Testing Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Infectious Disease Diagnostics Testing Sales by Country
- 8.6.2 South America Infectious Disease Diagnostics Testing Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Infectious Disease Diagnostics Testing Sales by Region
- 8.7.2 Middle East and Africa Infectious Disease Diagnostics Testing Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Infectious Disease Diagnostics Testing Market Production by Region
- 9.1 Global Production of Infectious Disease Diagnostics Testing by Region(2020-2025)
- 9.2 Global Infectious Disease Diagnostics Testing Revenue Market Share by Region (2020-2025)
- 9.3 Global Infectious Disease Diagnostics Testing Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Infectious Disease Diagnostics Testing Production
- 9.4.1 North America Infectious Disease Diagnostics Testing Production Growth Rate (2020-2025)
- 9.4.2 North America Infectious Disease Diagnostics Testing Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Infectious Disease Diagnostics Testing Production
- 9.5.1 Europe Infectious Disease Diagnostics Testing Production Growth Rate (2020-2025)
- 9.5.2 Europe Infectious Disease Diagnostics Testing Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Infectious Disease Diagnostics Testing Production (2020-2025)
- 9.6.1 Japan Infectious Disease Diagnostics Testing Production Growth Rate (2020-2025)
- 9.6.2 Japan Infectious Disease Diagnostics Testing Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Infectious Disease Diagnostics Testing Production (2020-2025)
- 9.7.1 China Infectious Disease Diagnostics Testing Production Growth Rate (2020-2025)
- 9.7.2 China Infectious Disease Diagnostics Testing Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Abbott_x000D_
- 10.1.1 Abbott_x000D_ Basic Information
- 10.1.2 Abbott_x000D_ Infectious Disease Diagnostics Testing Product Overview
- 10.1.3 Abbott_x000D_ Infectious Disease Diagnostics Testing Product Market Performance
- 10.1.4 Abbott_x000D_ Business Overview
- 10.1.5 Abbott_x000D_ SWOT Analysis
- 10.1.6 Abbott_x000D_ Recent Developments
- 10.2 bioMérieux_x000D_
- 10.2.1 bioMérieux_x000D_ Basic Information
- 10.2.2 bioMérieux_x000D_ Infectious Disease Diagnostics Testing Product Overview
- 10.2.3 bioMérieux_x000D_ Infectious Disease Diagnostics Testing Product Market Performance
- 10.2.4 bioMérieux_x000D_ Business Overview
- 10.2.5 bioMérieux_x000D_ SWOT Analysis
- 10.2.6 bioMérieux_x000D_ Recent Developments
- 10.3 Diasorin_x000D_
- 10.3.1 Diasorin_x000D_ Basic Information
- 10.3.2 Diasorin_x000D_ Infectious Disease Diagnostics Testing Product Overview
- 10.3.3 Diasorin_x000D_ Infectious Disease Diagnostics Testing Product Market Performance
- 10.3.4 Diasorin_x000D_ Business Overview
- 10.3.5 Diasorin_x000D_ SWOT Analysis
- 10.3.6 Diasorin_x000D_ Recent Developments
- 10.4 Roche Diagnostic_x000D_
- 10.4.1 Roche Diagnostic_x000D_ Basic Information
- 10.4.2 Roche Diagnostic_x000D_ Infectious Disease Diagnostics Testing Product Overview
- 10.4.3 Roche Diagnostic_x000D_ Infectious Disease Diagnostics Testing Product Market Performance
- 10.4.4 Roche Diagnostic_x000D_ Business Overview
- 10.4.5 Roche Diagnostic_x000D_ Recent Developments
- 10.5 Beckman Coulter_x000D_
- 10.5.1 Beckman Coulter_x000D_ Basic Information
- 10.5.2 Beckman Coulter_x000D_ Infectious Disease Diagnostics Testing Product Overview
- 10.5.3 Beckman Coulter_x000D_ Infectious Disease Diagnostics Testing Product Market Performance
- 10.5.4 Beckman Coulter_x000D_ Business Overview
- 10.5.5 Beckman Coulter_x000D_ Recent Developments
- 10.6 Becton, Dickinson and Company_x000D_
- 10.6.1 Becton, Dickinson and Company_x000D_ Basic Information
- 10.6.2 Becton, Dickinson and Company_x000D_ Infectious Disease Diagnostics Testing Product Overview
- 10.6.3 Becton, Dickinson and Company_x000D_ Infectious Disease Diagnostics Testing Product Market Performance
- 10.6.4 Becton, Dickinson and Company_x000D_ Business Overview
- 10.6.5 Becton, Dickinson and Company_x000D_ Recent Developments
- 10.7 Bio-Rad Laboratories_x000D_
- 10.7.1 Bio-Rad Laboratories_x000D_ Basic Information
- 10.7.2 Bio-Rad Laboratories_x000D_ Infectious Disease Diagnostics Testing Product Overview
- 10.7.3 Bio-Rad Laboratories_x000D_ Infectious Disease Diagnostics Testing Product Market Performance
- 10.7.4 Bio-Rad Laboratories_x000D_ Business Overview
- 10.7.5 Bio-Rad Laboratories_x000D_ Recent Developments
- 10.8 Cavidi_x000D_
- 10.8.1 Cavidi_x000D_ Basic Information
- 10.8.2 Cavidi_x000D_ Infectious Disease Diagnostics Testing Product Overview
- 10.8.3 Cavidi_x000D_ Infectious Disease Diagnostics Testing Product Market Performance
- 10.8.4 Cavidi_x000D_ Business Overview
- 10.8.5 Cavidi_x000D_ Recent Developments
- 10.9 Cepheid_x000D_
- 10.9.1 Cepheid_x000D_ Basic Information
- 10.9.2 Cepheid_x000D_ Infectious Disease Diagnostics Testing Product Overview
- 10.9.3 Cepheid_x000D_ Infectious Disease Diagnostics Testing Product Market Performance
- 10.9.4 Cepheid_x000D_ Business Overview
- 10.9.5 Cepheid_x000D_ Recent Developments
- 10.10 Corgenix_x000D_
- 10.10.1 Corgenix_x000D_ Basic Information
- 10.10.2 Corgenix_x000D_ Infectious Disease Diagnostics Testing Product Overview
- 10.10.3 Corgenix_x000D_ Infectious Disease Diagnostics Testing Product Market Performance
- 10.10.4 Corgenix_x000D_ Business Overview
- 10.10.5 Corgenix_x000D_ Recent Developments
- 10.11 Diaxonhit_x000D_
- 10.11.1 Diaxonhit_x000D_ Basic Information
- 10.11.2 Diaxonhit_x000D_ Infectious Disease Diagnostics Testing Product Overview
- 10.11.3 Diaxonhit_x000D_ Infectious Disease Diagnostics Testing Product Market Performance
- 10.11.4 Diaxonhit_x000D_ Business Overview
- 10.11.5 Diaxonhit_x000D_ Recent Developments
- 10.12 Eiken Chemical_x000D_
- 10.12.1 Eiken Chemical_x000D_ Basic Information
- 10.12.2 Eiken Chemical_x000D_ Infectious Disease Diagnostics Testing Product Overview
- 10.12.3 Eiken Chemical_x000D_ Infectious Disease Diagnostics Testing Product Market Performance
- 10.12.4 Eiken Chemical_x000D_ Business Overview
- 10.12.5 Eiken Chemical_x000D_ Recent Developments
- 10.13 EMD Millipore_x000D_
- 10.13.1 EMD Millipore_x000D_ Basic Information
- 10.13.2 EMD Millipore_x000D_ Infectious Disease Diagnostics Testing Product Overview
- 10.13.3 EMD Millipore_x000D_ Infectious Disease Diagnostics Testing Product Market Performance
- 10.13.4 EMD Millipore_x000D_ Business Overview
- 10.13.5 EMD Millipore_x000D_ Recent Developments
- 10.14 Epitope Diagnostic_x000D_
- 10.14.1 Epitope Diagnostic_x000D_ Basic Information
- 10.14.2 Epitope Diagnostic_x000D_ Infectious Disease Diagnostics Testing Product Overview
- 10.14.3 Epitope Diagnostic_x000D_ Infectious Disease Diagnostics Testing Product Market Performance
- 10.14.4 Epitope Diagnostic_x000D_ Business Overview
- 10.14.5 Epitope Diagnostic_x000D_ Recent Developments
- 10.15 EUROIMMUN_x000D_
- 10.15.1 EUROIMMUN_x000D_ Basic Information
- 10.15.2 EUROIMMUN_x000D_ Infectious Disease Diagnostics Testing Product Overview
- 10.15.3 EUROIMMUN_x000D_ Infectious Disease Diagnostics Testing Product Market Performance
- 10.15.4 EUROIMMUN_x000D_ Business Overview
- 10.15.5 EUROIMMUN_x000D_ Recent Developments
- 10.16 Gold Standard Diagnostics_x000D_
- 10.16.1 Gold Standard Diagnostics_x000D_ Basic Information
- 10.16.2 Gold Standard Diagnostics_x000D_ Infectious Disease Diagnostics Testing Product Overview
- 10.16.3 Gold Standard Diagnostics_x000D_ Infectious Disease Diagnostics Testing Product Market Performance
- 10.16.4 Gold Standard Diagnostics_x000D_ Business Overview
- 10.16.5 Gold Standard Diagnostics_x000D_ Recent Developments
- 10.17 Hologic_x000D_
- 10.17.1 Hologic_x000D_ Basic Information
- 10.17.2 Hologic_x000D_ Infectious Disease Diagnostics Testing Product Overview
- 10.17.3 Hologic_x000D_ Infectious Disease Diagnostics Testing Product Market Performance
- 10.17.4 Hologic_x000D_ Business Overview
- 10.17.5 Hologic_x000D_ Recent Developments
- 10.18 Immunetics_x000D_
- 10.18.1 Immunetics_x000D_ Basic Information
- 10.18.2 Immunetics_x000D_ Infectious Disease Diagnostics Testing Product Overview
- 10.18.3 Immunetics_x000D_ Infectious Disease Diagnostics Testing Product Market Performance
- 10.18.4 Immunetics_x000D_ Business Overview
- 10.18.5 Immunetics_x000D_ Recent Developments
- 10.19 InBios International
- 10.19.1 InBios International Basic Information
- 10.19.2 InBios International Infectious Disease Diagnostics Testing Product Overview
- 10.19.3 InBios International Infectious Disease Diagnostics Testing Product Market Performance
- 10.19.4 InBios International Business Overview
- 10.19.5 InBios International Recent Developments
- 11 Infectious Disease Diagnostics Testing Market Forecast by Region
- 11.1 Global Infectious Disease Diagnostics Testing Market Size Forecast
- 11.2 Global Infectious Disease Diagnostics Testing Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Infectious Disease Diagnostics Testing Market Size Forecast by Country
- 11.2.3 Asia Pacific Infectious Disease Diagnostics Testing Market Size Forecast by Region
- 11.2.4 South America Infectious Disease Diagnostics Testing Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Infectious Disease Diagnostics Testing by Country
- 12 Forecast Market by Type and by Application (2026-2033)
- 12.1 Global Infectious Disease Diagnostics Testing Market Forecast by Type (2026-2033)
- 12.1.1 Global Forecasted Sales of Infectious Disease Diagnostics Testing by Type (2026-2033)
- 12.1.2 Global Infectious Disease Diagnostics Testing Market Size Forecast by Type (2026-2033)
- 12.1.3 Global Forecasted Price of Infectious Disease Diagnostics Testing by Type (2026-2033)
- 12.2 Global Infectious Disease Diagnostics Testing Market Forecast by Application (2026-2033)
- 12.2.1 Global Infectious Disease Diagnostics Testing Sales (K Units) Forecast by Application
- 12.2.2 Global Infectious Disease Diagnostics Testing Market Size (M USD) Forecast by Application (2026-2033)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
